Russell Investments Group, Ltd.

Position in EYPT — EyePoint, Inc.

CIK 1692234 Seattle, WA

Position in EYPT

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$923,322

+$814,287 QoQ

Shares Held

71,631

+1100.3% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 86.78225907777359.ToString("F0")% Shared 0.ToString("F0")% None 13.21774092222641.ToString("F0")%

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. EYPT ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	228,086	$176,228,356
2	VRTX	Vertex Pharmaceuticals Inc / Ma	367,691	$164,188,731
3	RPRX	Royalty Pharma plc	1,397,958	$67,060,041
4	INCY	Incyte Corp	638,242	$60,071,331
5	ALNY	Alnylam Pharmaceuticals, Inc.	147,533	$48,814,236
6	MRNA	Moderna, Inc.	710,640	$36,100,509
7	BMRN	Biomarin Pharmaceutical Inc	606,224	$34,245,589
8	INSM	INSMED Inc	169,162	$27,661,365

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$923,322	71,631	+1100.3%	Shares	Defined	2026-05-08
2025-12-31	$109,035	5,968	+11.5%	Shares	Defined	2026-02-17
2025-09-30	$76,212	5,352	+365.8%	Shares	Defined	2025-11-13
2025-03-31	$6,227	1,149	+4687.5%	Shares	Other	2025-05-13
2024-09-30	$191	24	-97.8%	Shares	Defined	2024-11-13
2024-06-30	$9,282	1,067	+5235.0%	Shares	Defined	2024-08-08
2024-03-31	$413	20	-99.9%	Shares	Defined	2024-05-08
2022-09-30	$223,876	28,303	0.0%	Shares	Defined	2022-11-04
2022-06-30	$222,744	28,303	—	Shares	Defined	2022-07-29
No filing history on record for this holder in this stock.